14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.52 $2.23 Tuesday, 23rd Apr 2024 CYCC stock ended at $1.79. This is 2.29% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 10.12% from a day low at $1.68 to a day high of $1.85.
90 days $1.52 $3.08
52 weeks $1.52 $13.20

Historical Cyclacel Pharmaceuticals prices

Date Open High Low Close Volume
Feb 17, 2021 $9.04 $9.05 $8.51 $8.95 566 763
Feb 16, 2021 $9.26 $9.53 $8.86 $9.14 660 046
Feb 12, 2021 $9.31 $9.69 $9.02 $9.12 597 145
Feb 11, 2021 $9.52 $10.27 $9.11 $9.69 1 052 759
Feb 10, 2021 $10.09 $10.18 $8.65 $9.45 1 891 902
Feb 09, 2021 $8.92 $11.42 $8.60 $10.16 9 890 686
Feb 08, 2021 $9.02 $9.55 $8.75 $9.15 1 929 789
Feb 05, 2021 $7.81 $10.62 $7.67 $8.82 6 815 681
Feb 04, 2021 $7.05 $7.75 $7.05 $7.65 456 982
Feb 03, 2021 $7.24 $7.39 $6.96 $7.01 278 426
Feb 02, 2021 $7.44 $7.44 $6.98 $7.25 209 186
Feb 01, 2021 $7.05 $7.67 $6.78 $7.35 676 133
Jan 29, 2021 $7.64 $7.76 $7.01 $7.03 194 230
Jan 28, 2021 $7.80 $7.85 $7.35 $7.60 519 488
Jan 27, 2021 $7.45 $8.13 $7.30 $7.39 400 148
Jan 26, 2021 $7.50 $7.59 $7.23 $7.56 217 061
Jan 25, 2021 $7.50 $7.62 $7.22 $7.35 310 111
Jan 22, 2021 $7.38 $7.52 $7.23 $7.43 145 097
Jan 21, 2021 $7.35 $7.47 $7.25 $7.36 121 421
Jan 20, 2021 $7.49 $7.63 $7.10 $7.21 209 466
Jan 19, 2021 $7.41 $7.77 $7.11 $7.55 469 114
Jan 15, 2021 $8.86 $9.02 $7.15 $7.35 1 040 795
Jan 14, 2021 $8.87 $9.46 $8.72 $9.01 192 768
Jan 13, 2021 $8.92 $9.02 $8.57 $8.86 174 655
Jan 12, 2021 $9.41 $9.77 $8.74 $8.83 257 404
Click to get the best stock tips daily for free!

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT